Taking decisions on expenditure for high‐cost drugs at the regional level: a model for evaluating the overall impact of Trastuzumab in the Veneto Region of Italy

, , , , , , , , &
Journal of Evaluation in Clinical Practice 17 (2):298-303 (2011)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1111/j.1365-2753.2010.01440.x

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 93,031

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Decision analysis model evaluating the cost‐effectiveness of risperidone, olanzapine and haloperidol in the treatment of schizophrenia.Mark Bounthavong & Mark P. Okamoto - 2007 - Journal of Evaluation in Clinical Practice 13 (3):453-460.
Decision modelling of economic evaluation of intervention programme of breast cancer.Jung-Chen Chang, Tony H.-H. Chen, Stephen W. Duffy, Amy M.-F. Yen & Sam L.-S. Chen - 2010 - Journal of Evaluation in Clinical Practice 16 (6):1282-1288.
Impact of cost containment measures on medical liability.S. Callens, I. Volbragt & H. Nys - 2006 - Journal of Evaluation in Clinical Practice 12 (6):595-600.
Cost‐utility analysis of bevacizumab versus ranibizumab in neovascular age‐related macular degeneration using a Markov model.Jignesh J. Patel, Margaret As Mendes, Mark Bounthavong, Melissa Ld Christopher, Daniel Boggie & Anthony P. Morreale - 2012 - Journal of Evaluation in Clinical Practice 18 (2):247-255.
The application of pharmacoeconomic modelling to estimate a value‐based price for new cancer drugs.George Dranitsaris, Ilse Truter, Martie S. Lubbe, Wayne Cottrell, Biljana Spirovski & Jonathan Edwards - 2012 - Journal of Evaluation in Clinical Practice 18 (2):343-351.
Impact of advanced exercise ECG analysis on cost of coronary artery disease management.Riccardo Bigi, Alberto Ferrando, Eva Pagano, Lauro Cortigiani, Franco Merletti, Cesare Fiorentini & Dario Gregori - 2010 - Journal of Evaluation in Clinical Practice 16 (4):678-684.
Cost of treatment of peripheral neuropathic pain with pregabalin or gabapentin in routine clinical practice: impact of their loss of exclusivity.Antoni Sicras-Mainar, Javier Rejas-Gutiérrez, María Pérez-Páramo & Ruth Navarro-Artieda - 2017 - Journal of Evaluation in Clinical Practice 23 (2):402-412.
Model‐based cost‐effectiveness analysis of interventions aimed at preventing medication error at hospital admission (medicines reconciliation).Jonathan Karnon, Fiona Campbell & Carolyn Czoski-Murray - 2009 - Journal of Evaluation in Clinical Practice 15 (2):299-306.
Cost and benefits of a multidisciplinary intensive diabetes education programme.J. C. Keers, H. Groen, W. J. Sluiter, J. Bouma & T. P. Links - 2005 - Journal of Evaluation in Clinical Practice 11 (3):293-303.
Performance: a multi‐disciplinary and conceptual model.Terry R. Lied & Vahe A. Kazandjian - 1999 - Journal of Evaluation in Clinical Practice 5 (4):393-400.

Analytics

Added to PP
2013-11-24

Downloads
39 (#420,937)

6 months
11 (#272,549)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references